VRX PRICE EXPECTED TO DOUBLE IN A COMING BULLISH R
Post# of 6
Posted On: 11/30/2015 12:38:52 PM
VRX PRICE EXPECTED TO DOUBLE IN A COMING BULLISH RALLY
Valeant Pharmaceuticals turns Bullish
Monday, 30 November 2015.
11/27/2015 - NASDAQ-surveyed analysts set the price target for Valeant Pharmaceuticals (NYSE:VRX) to $172. NASDAQ maintains STRONG BULLISH rating on Valeant Pharmaceuticals.
11/24/2015 - Valeant Pharmaceuticals Intl (NYSE:VRX) had its price objective set by Guggenheim to $195.00.
11/20/2015 – Valeant Pharmaceuticals Intl (VRX) had its price target set at$111 by analysts at Mizuho. They now have a “BUY” rating on the stock.
11/19/2015 – Valeant Pharmaceuticals Intl had its “BUY” rating reaffirmed by analysts at Canaccord Genuity. They now have a $170.00 price target on the stock.
11/19/2015 – Valeant Pharmaceuticals Intl is now covered by analysts atCitigroup Inc. They set an “overweight” rating on the stock with a “BUY”recomendation.
11/17/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts at Morgan Stanley to $98.00. They now have an “equal weight” rating on the stock and recommend a “BUY.”
11/12/2015 – Valeant Pharmaceuticals Intl had its “BUY” rating reaffirmed by analysts at Bank of America.
11/12/2015 – Valeant Pharmaceuticals Intl had its “HOLD” rating reaffirmed by analysts at Deutsche Bank.
11/11/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atTD Securities to $160.00. They now have a “BUY” rating on the stock.
11/11/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atRBC Capital to $206.00. They now have an “OUTPERFORM” rating on the stock.
11/11/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atStifel Nicolaus to $200.00. They now have a “BUY” rating on the stock.
11/11/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atJPMorgan Chase & Co. to $225.00. They now have an “OVERWEIGHT”rating on the stock.
11/11/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atNomura to $175.00. They now have a “BUY” rating on the stock.
11/6/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atGuggenheim to $195.00. They now have a “buy” rating on the stock.
11/5/2015 – Valeant Pharmaceuticals Intl had its “BUY” rating reaffirmed by analysts at Mizuho.
11/3/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atDeutsche Bank to $136.00. They now have a “HOLD” rating on the stock.
11/3/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atRBC Capital to $213.00. They now have an “outperform” rating on the stock.
11/3/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atBMO Capital Markets to $133.00. They now have a “MARKET PERFORM” rating on the stock.
11/2/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atScotiabank to US$170.00.
11/2/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atJefferies Group to US$172.00. They now have a “BUY” rating on the stock.
11/2/2015 – Valeant Pharmaceuticals Intl had its “BUY” rating reaffirmed by analysts at Canaccord Genuity. They now have a $170.00 price target on the stock.
11/2/2015 – Valeant Pharmaceuticals Intl was target price was set by analysts at Goldman Sachs to $122.00 price target on the stock.
11/1/2015 – Valeant Pharmaceuticals Intl had its “BUY” rating reaffirmed by analysts at Bank of America. They now have a US$173.00 price target on the stock.
11/1/2015 – Valeant Pharmaceuticals Intl had its “EQUAL WEIGHT” rating reaffirmed by analysts at Morgan Stanley.
11/1/2015 – Valeant Pharmaceuticals Intl had its “BUY” rating reaffirmed by analysts at Stifel Nicolaus. They now have a $285.00 price target on the stock.
Valeant Pharmaceuticals turns Bullish
Monday, 30 November 2015.
11/27/2015 - NASDAQ-surveyed analysts set the price target for Valeant Pharmaceuticals (NYSE:VRX) to $172. NASDAQ maintains STRONG BULLISH rating on Valeant Pharmaceuticals.
11/24/2015 - Valeant Pharmaceuticals Intl (NYSE:VRX) had its price objective set by Guggenheim to $195.00.
11/20/2015 – Valeant Pharmaceuticals Intl (VRX) had its price target set at$111 by analysts at Mizuho. They now have a “BUY” rating on the stock.
11/19/2015 – Valeant Pharmaceuticals Intl had its “BUY” rating reaffirmed by analysts at Canaccord Genuity. They now have a $170.00 price target on the stock.
11/19/2015 – Valeant Pharmaceuticals Intl is now covered by analysts atCitigroup Inc. They set an “overweight” rating on the stock with a “BUY”recomendation.
11/17/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts at Morgan Stanley to $98.00. They now have an “equal weight” rating on the stock and recommend a “BUY.”
11/12/2015 – Valeant Pharmaceuticals Intl had its “BUY” rating reaffirmed by analysts at Bank of America.
11/12/2015 – Valeant Pharmaceuticals Intl had its “HOLD” rating reaffirmed by analysts at Deutsche Bank.
11/11/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atTD Securities to $160.00. They now have a “BUY” rating on the stock.
11/11/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atRBC Capital to $206.00. They now have an “OUTPERFORM” rating on the stock.
11/11/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atStifel Nicolaus to $200.00. They now have a “BUY” rating on the stock.
11/11/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atJPMorgan Chase & Co. to $225.00. They now have an “OVERWEIGHT”rating on the stock.
11/11/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atNomura to $175.00. They now have a “BUY” rating on the stock.
11/6/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atGuggenheim to $195.00. They now have a “buy” rating on the stock.
11/5/2015 – Valeant Pharmaceuticals Intl had its “BUY” rating reaffirmed by analysts at Mizuho.
11/3/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atDeutsche Bank to $136.00. They now have a “HOLD” rating on the stock.
11/3/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atRBC Capital to $213.00. They now have an “outperform” rating on the stock.
11/3/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atBMO Capital Markets to $133.00. They now have a “MARKET PERFORM” rating on the stock.
11/2/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atScotiabank to US$170.00.
11/2/2015 – Valeant Pharmaceuticals Intl had its price target set by analysts atJefferies Group to US$172.00. They now have a “BUY” rating on the stock.
11/2/2015 – Valeant Pharmaceuticals Intl had its “BUY” rating reaffirmed by analysts at Canaccord Genuity. They now have a $170.00 price target on the stock.
11/2/2015 – Valeant Pharmaceuticals Intl was target price was set by analysts at Goldman Sachs to $122.00 price target on the stock.
11/1/2015 – Valeant Pharmaceuticals Intl had its “BUY” rating reaffirmed by analysts at Bank of America. They now have a US$173.00 price target on the stock.
11/1/2015 – Valeant Pharmaceuticals Intl had its “EQUAL WEIGHT” rating reaffirmed by analysts at Morgan Stanley.
11/1/2015 – Valeant Pharmaceuticals Intl had its “BUY” rating reaffirmed by analysts at Stifel Nicolaus. They now have a $285.00 price target on the stock.
(0)
(0)